Literature DB >> 21436242

Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret.

Soichiro Kanoh1, Tsuyoshi Tanabe1, Bruce K Rubin2.   

Abstract

BACKGROUND: IL-8 is an important activator and chemoattractant for neutrophils that is produced by normal human bronchial epithelial (NHBE) cells through mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) p65 pathways. Dapsone, a synthetic sulfone, is widely used to treat chronic neutrophil dermatoses. We investigated the effects of dapsone on polarized IL-8 secretion from lipopolysaccharide (LPS)-stimulated NHBE cells and further evaluated its ability to decrease LPS-induced inflammation in the ferret airway.
METHODS: NHBE cells were grown at air-liquid interface (ALI) to ciliated differentiation. Baseline and endotoxin (LPS)-stimulated IL-8 secretion was measured by enzyme-linked immunosorbent assay at air and basal sides with and without dapsone. Western blotting was used to determine signaling pathways. In vivo, ferrets were exposed to intratracheal LPS over a period of 5 days. Once inflammation was established, oral or nebulized dapsone was administered for 5 days. Intraepithelial neutrophil accumulation was analyzed histologically, and mucociliary transport was measured on the excised trachea.
RESULTS: Dapsone, 1 μg/mL, did not influence unstimulated (basal) IL-8 secretion. Apical LPS stimulation induced both apical and basolateral IL-8, but basolateral LPS increased only basolateral IL-8. Dapsone inhibited polarized IL-8 secretion from ALI-conditioned cells. Dapsone also decreased LPS-induced IL-8 mRNA level. LPS led to phosphorylation of extracellular signal-regulated kinase 1/2, but not p38 MAPK or c-Jun NH(2)-terminal kinase. LPS also induced NF-κB p65 phosphorylation, an effect that was inhibited by dapsone. Both oral and aerosol dapsone decreased LPS-induced intraepithelial neutrophil accumulation, but only treatment with aerosol dapsone restored mucociliary transport to normal.
CONCLUSIONS: Dapsone, given either systemically or as an aerosol, may be useful in treating neutrophilic airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436242     DOI: 10.1378/chest.10-2908

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression.

Authors:  Lan Dai; Liying Gu; Wen Di
Journal:  Mol Hum Reprod       Date:  2011-10-11       Impact factor: 4.025

2.  Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.

Authors:  Chuntao Wang; Qingnian Li; Tianyu Li
Journal:  Exp Lung Res       Date:  2020-01-14       Impact factor: 2.459

3.  Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats.

Authors:  Mohammad Sheibani; Sadaf Nezamoleslami; Hedyeh Faghir-Ghanesefat; Amir Hossein Emami; Ahmad Reza Dehpour
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-08       Impact factor: 3.333

Review 4.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

5.  Secretory phospholipases A2 are secreted from ciliated cells and increase mucin and eicosanoid secretion from goblet cells.

Authors:  Tsuyoshi Tanabe; Tadasuke Shimokawaji; Soichiro Kanoh; Bruce K Rubin
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

6.  MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells.

Authors:  Jyoti Thaikoottathil; Hong Wei Chu
Journal:  Mol Immunol       Date:  2011-09-06       Impact factor: 4.407

Review 7.  A comprehensive insight into the anti-inflammatory properties of dapsone.

Authors:  Mina Khalilzadeh; Maryam Shayan; Sina Jourian; Mohammad Rahimi; Mohammad Sheibani; Ahmad Reza Dehpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-20       Impact factor: 3.195

8.  IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells.

Authors:  T Tanabe; T Shimokawaji; S Kanoh; B K Rubin
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

9.  Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.

Authors:  R E Kast
Journal:  Springerplus       Date:  2015-10-23

10.  Dapsone modulates lipopolysaccharide-activated bone marrow cells by inducing cell death and down-regulating tumor necrosis factor-α production.

Authors:  Min-Ji Kwon; Hong-Gu Joo
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.